A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy - Archive ouverte HAL Access content directly
Journal Articles European Journal of Translational Myology Year : 2021

A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy

(1) , (1) , (1) , (1)
1

Abstract

We recently identified a signaling pathway that links the upregulation of miR-379 with a mitochondrial response in dystrophic muscle. In the present commentary, we explain the significance that this pathway may have in mitochondrial dysfunction in Duchenne muscular dystrophy (DMD). We identified the upregulation of miR-379 in the serum and muscles of DMD animal models and patients. We found that miR-379 is one of very few miRNAs whose expression was normalized in DMD patients treated with glucocorticoid. We identified EIF4G2 as a miR-379 target, which may promote mitochondrial oxidative phosphorylation (OxPhos) in the skeletal muscle. We found enriched EIF4G2 expression in oxidative fibers, and identified the mitochondrial ATP synthase subunit DAPIT as a translational target of EIF4G2. The identified signaling cascade, which comprises miR-379, EIF4G2 and DAPIT, may link the glucocorticoid treatment in DMD to a recovered mitochondrial ATP synthesis rate. We propose an updated model of mitochondrial dysfunction in DMD.
Fichier principal
Vignette du fichier
Ejtm 31(3) #10012 Co-Israeli RELEASED Sep20.pdf (193.31 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03358240 , version 1 (17-11-2021)
hal-03358240 , version 2 (29-11-2021)

Identifiers

Cite

Ai Vu Hong, Mathilde Sanson, Isabelle Richard, David Israeli. A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy. European Journal of Translational Myology, 2021, 31 (3), ⟨10.4081/ejtm.2021.10012⟩. ⟨hal-03358240v2⟩
54 View
43 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More